KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Cash (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Change in Cash for 11 consecutive years, with $211.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 1588.72% year-over-year to $211.7 million, compared with a TTM value of -$172.4 million through Dec 2025, down 140.66%, and an annual FY2025 reading of -$172.4 million, down 140.66% over the prior year.
  • Change in Cash was $211.7 million for Q4 2025 at Medpace Holdings, down from $239.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $239.0 million in Q3 2025 and bottomed at -$395.1 million in Q2 2025.
  • Average Change in Cash over 5 years is $11.0 million, with a median of $36.9 million recorded in 2021.
  • The sharpest move saw Change in Cash plummeted 786.72% in 2022, then soared 5579.29% in 2023.
  • Year by year, Change in Cash stood at $62.9 million in 2021, then plummeted by 104.36% to -$2.7 million in 2022, then skyrocketed by 5579.29% to $150.2 million in 2023, then crashed by 91.66% to $12.5 million in 2024, then soared by 1588.72% to $211.7 million in 2025.
  • Business Quant data shows Change in Cash for MEDP at $211.7 million in Q4 2025, $239.0 million in Q3 2025, and -$395.1 million in Q2 2025.